Rabies Vaccine BP is an inactivated vaccine indicated for prophylactic immunisation against rabies and treatment of patients following suspected rabies contact.
Rabies is an acute viral infection causing inflammation of the spinal cord and the brain1 that leads to the deaths of tens of thousands of people worldwide.2 In developing countries, where it is most often transmitted by stray dogs, rabies is still considered a major public health concern.2
Transmitted through the saliva of an infected mammal, usually via a bite, scratch of lick3 The incubation period for the disease is usually 1-3 months but can be anything from a week to 1 year.2
Vaccination may be considered for all travellers who will be living or visiting endemic areas especially if:3
Rabies Vaccine BP can be used to help provide pre-exposure prophylaxis and also as post-exposure treatment.
Rabies vaccine ≥ 2.5 IU/ml (inactivated)
|Presentation||1 ml prefilled diluent syringe + vial of lyophilised powder
Available in 1 vial
+ 1 syringe packs
3 doses at 0, 7 and 21 or 28 days Post-exposure prophylaxis:
- In persons known to have adequate prophylaxis two further boosters should be given, one on day 0 and one on day 3
- In persons with no, or possibly inadequate, prophylaxis the first injection of rabies vaccine (day 0) should be given as soon as possible after the suspected contact and followed by four further doses on days 3, 7, 14, and 30
For those at regular and continuing risk, a single reinforcing dose of vaccine should be given at 1 year after the primary course has been completed. Further doses should be given at three to five-year intervals thereafter For travellers at intermittent risk of exposure, booster doses may be given in line with official recommendations
No lower or upper age limit listed
Sanofi Pasteur is committed to providing you and your patients with a comprehensive range of support materials, including disease awareness patient leaflets and in-surgery display items.
• Simply visit https://sanofi.medisa.com
• Select the user group which best describes your role in your organisation
• Narrow your search by selecting the appropriate disease area
• Select which materials you would like to receive and how many
• Log-in or register to create an account
• Confirm your order
Date of preparation: November 2018 | SAGB.MIS.18.08.1323t